SCHEMBL8776855

SCHEMBL8776855

N#Cc1cccnc1OCc1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
XDH P47989 1/20 0.42
MGMT P16455 1/20 0.42
MAOB P27338 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABCB1 P08183 1/20 0.39
SQOR Q9Y6N5 1/20 0.38
SSTR4 P31391 1/20 0.38
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
PGGT1B P53609 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034458 0.90 MAOB (0.51) MAOBCYP3A4SQORFNTAFNTB
SCHEMBL8808187 0.80 ABCB1 (0.53) MKNK1MKNK2XDHCYP3A4ABCB1
SCHEMBL15831936 0.78 HDAC1 (0.52) MKNK1MKNK2XDHMGMT
SCHEMBL249966 0.77 L3MBTL1 (0.49) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL3660182 0.77 NPC1 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL8784748 0.75 ABCB1 (0.58) XDHCYP3A4ABCB1FNTAFNTB
SCHEMBL2526961 0.75 SLC6A4 (0.46) MKNK1MKNK2XDHMGMT
SCHEMBL3432978 0.75 NPC1 (0.43) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL564714 0.75 HPGD (0.43) CYP1A2CYP3A4CYP2D6CYP2C9HPGD
SCHEMBL3803808 0.75 NPC1 (0.43) CYP1A2CYP3A4CYP2D6CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed